Conference Coverage

Early data indicate D-cycloserine augments effects of virtual reality treatment for PTSD


 

EXPERT ANALYSIS AT THE 2014 APA CONVENTION

References

Dr. Difede, also director of the program for anxiety and traumatic stress studies at New York-Presbyterian Hospital, said the two groups began to diverge at the third session, and those who received DCS continued to improve 6 months later. A post-hoc analysis identified a "drastic improvement" in anger and sleep among those treated with DCS, a finding that she and her associates plan to look at more closely. The study presented by Dr. Jovanovic was funded by the National Institute of Mental Health. Dr. Difede received partial funding support from DeWitt-Wallace Fund of the New York Community Trust. The trust was not involved in the design, data collection, or in any other aspects of the study.

emechcatie@frontlinemedcom.com

Pages

Recommended Reading

100 years of solicitude: Do global traumatic events have a transgenerational effect?
MDedge Psychiatry
Treating PTSD and its effects here at home
MDedge Psychiatry
General screening for suicide not recommended yet
MDedge Psychiatry
PTSD symptoms a common complication of critical illness
MDedge Psychiatry
VIDEO: PTSD common in survivors of critical illness
MDedge Psychiatry
IOM: Military, veterans’ PTSD programs lack consistency, outcomes measures
MDedge Psychiatry
Post-World War II psychiatry: 70 years of momentous change
MDedge Psychiatry
Chronic pain and opioid use much higher among soldiers
MDedge Psychiatry
VIDEO: Dementia risk spikes in older veterans with sleep disorders, PTSD
MDedge Psychiatry
PTSD ‘updates’ in DSM-5 concerning
MDedge Psychiatry